Physician profile
Janice M Fields
NPI 1346223609
$10,111.11
in general payments reported to CMS, 2019-2025
40 companies · $1,712 in 2025
The $1,712 reported for 2025 was more than what 75% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,601 · 2020: $333 · 2021: $1,263 · 2022: $1,817 · 2023: $1,974 · 2024: $1,412 · 2025: $1,712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,075 · Education: $22.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,075.20 |
| Education | $22.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,674.98 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $1,496.04 | 2019-2025 | Entyvio, Eohilia |
| Janssen Biotech, INC. | $884.58 | 2019-2025 | Tremfya, Stelara, Simponi |
| Celgene Corporation | $799.30 | 2021-2024 | Zeposia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $751.55 | 2019-2024 | Xifaxan, Plenvu, Trulance |
| Gilead Sciences, INC. | $563.00 | 2019-2025 | |
| Lilly USA, LLC | $306.06 | 2024-2025 | Omvoh |
| Pfizer INC. | $227.98 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $212.83 | 2022-2025 | Dupixent |
| Ironwood Pharmaceuticals, INC | $194.56 | 2019-2023 | Linzess |
| Qol Medical, LLC | $183.88 | 2019-2025 | Sucraid, Sucraid |
| Intercept Pharmaceuticals, INC. | $173.69 | 2019-2025 | Ocaliva |
| Ardelyx, INC. | $165.50 | 2022-2025 | Ibsrela |
| Amgen INC. | $161.30 | 2022-2023 | Avsola, Amjevita |
| Ferring Pharmaceuticals INC. | $124.36 | 2021-2023 | Rebyota |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.